SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-308366
Filing Date
2020-12-02
Accepted
2020-12-02 16:00:54
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d85337d424b5.htm 424B5 467636
2 GRAPHIC g50025g60d80.jpg GRAPHIC 28932
3 GRAPHIC g85337g02q26.jpg GRAPHIC 45051
4 GRAPHIC g85337g59h86.jpg GRAPHIC 32145
  Complete submission text file 0001193125-20-308366.txt   603038
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-251022 | Film No.: 201363752
SIC: 2835 In Vitro & In Vivo Diagnostic Substances